by Yana Nebuchina | Oct 23, 2019 | Commentary |
Cannabidiol (CBD) has the potential to be big business. Since the descheduling of hemp-derived CBD, large corporations have been exploring how they might capitalize on CBD’s hold on the public’s attention. CVS and Walgreens announced their rollout of CBD products in...
by Lin Sun | Sep 8, 2019 | Commentary |
I first learned of CAR-T cell therapy in 2015 while working in an immunology lab. It immediately caught my attention as a brilliant, unconventional cancer treatment: it modifies a patient’s own T cells and enlists them to fight cancer. T cells can recognize non-self...
by Fiona Gaul | Sep 8, 2019 | Commentary |
Virtual reality is more lifelike than ever before — not only can users see and hear the virtual world, but they can now feel and smell it too. Two major industries embracing this technology are gaming and mental health treatment. In both fields, the ability for users...
by Philip Brown | Sep 8, 2019 | Commentary |
When the term blockchain is thrown around, most people think about Bitcoin, Ethereum, and other cryptocurrencies that often populate headlines. While blockchain technology gained popularity and recognition in the area of cryptocurrencies and financial transactions, at...
by Olivia Wheeling | Sep 8, 2019 | Commentary |
Did Apple hack users’ devices? That is the allegation in a class action lawsuit filed late last year. Specifically, the plaintiffs in In re Apple Inc. Device Performance Litig., 347 F. Supp. 3d 434, 451 (N.D. Cal. 2018) allege that Apple’s battery-slowing iOS updates...
by Taylor Brook | Apr 25, 2019 | Commentary |
Technology developers will never stop in their quest to create what they’ve determined to be the height of convenience for their customers. While it is admirable and exciting for a consumer to always be on the cusp of the newest in technology, it comes with bumps in...